Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Pediatric Blood & Cancer|October 25, 2013
Neoplastic causes of abnormal pubertySusanne Wendt, John Shelso, Karen Wright, et al.Pediatric Blood & Cancer|April 5, 2005
Allogeneic graft-versus-hepatoblastoma effectHiroto Inaba, Rupert Handgretinger, Wayne Furman, et al.American Journal of Medical Genetics. Part A|April 2, 2011
Wilms tumor in a patient with 22q11.2 microdeletionPaul T Finch, Eniko K Pivnick, Wayne Furman, et al.Clinical and Translational Science|June 1, 2021
Pharmacokinetically guided dosing of oral sorafenib in pediatric hepatocellular carcinoma: A simulation studyJohn C Panetta, Olivia Campagne, Jessica Gartrell, et al.Journal of Pediatric Hematology/Oncology|November 12, 2020
Induction Chemotherapy With an Anti-GD2 Monoclonal Antibody (Dinutuximab) and Cytokines in Children With Newly Diagnosed High-risk Neuroblastoma: A Case SeriesJessica Gartrell, Barry L Shulkin, Sara Helmig, et al.Pediatric Blood & Cancer|February 8, 2011
Severe H1N1-associated acute respiratory failure in immunocompromised childrenLama Elbahlawan, Aditya H Gaur, Wayne Furman, et al.Cancer|May 20, 2008
Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcomaFariba Navid, Jennifer Reikes Willert, M Beth McCarville, et al.The American Journal of Hospice & Palliative Care|August 18, 2018
Bisphosphonate Use in Pediatric Oncology for Pain ManagementDoralina L Anghelescu, Varayini Pankayatselvan, Rosa Nguyen, et al.Pediatric Blood & Cancer|August 14, 2019
Secondary hemophagocytic syndrome after autologous hematopoietic cell transplant and immune therapy for neuroblastomaRebecca Epperly, Wayne Furman, Melissa Hines, et al.Journal of Pediatric Hematology/Oncology|July 9, 2003
Phase I trial of rebeccamycin analog (NSC #655649) in children with refractory solid tumors: a pediatric oncology group studyAnne-Marie Langevin, Steven D Weitman, John G Kuhn, et al.Pageof 2